Evidence-Based Medicine Guidelines
Oral antiviral agents for prevention of herpes simplex labialis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Antiviral Agents for Prevention of Herpes Simplex Labialis." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305016/all/Oral_antiviral_agents_for_prevention_of_herpes_simplex_labialis.
Oral antiviral agents for prevention of herpes simplex labialis. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305016/all/Oral_antiviral_agents_for_prevention_of_herpes_simplex_labialis. Accessed March 17, 2025.
Oral antiviral agents for prevention of herpes simplex labialis. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305016/all/Oral_antiviral_agents_for_prevention_of_herpes_simplex_labialis
Oral Antiviral Agents for Prevention of Herpes Simplex Labialis [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305016/all/Oral_antiviral_agents_for_prevention_of_herpes_simplex_labialis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral antiviral agents for prevention of herpes simplex labialis
ID - 1305016
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305016/all/Oral_antiviral_agents_for_prevention_of_herpes_simplex_labialis
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
